Sprint just announced the world's first connected payment card at CES. Sprint's Ivo Rook joins Cheddar to tells us about the future of payments, and the company's recent advancements in the space. Rook is the first to hold the newly-created position and reveals his priorities for 2018 and beyond.
Sprint and Dynamics unveiled Wallet Card at the Las Vegas electronics expo. He explains what's possible, thanks to the new tech that connected payment option. The card can switch from a credit card to a debit card and back again in addition to storing personal information.
Finally, Rook breaks down his predictions for the future of IOT. He also showcases Sprint's advancements in the space and what it has that other competitors do not. He details how the company plans on leveraging its relationship with SoftBank to expand its IOT initiatives.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
